Zdrowie i gospodarka · 16/11/2001

FDA Releases Draft Guidance for Electronic ANDA Submissions

The Food and Drug Administration (FDA) has made available a draft guidance document outlining the process for submitting abbreviated new drug applications (ANDAs) in electronic format, aimed at facilitating the regulatory submission process for pharmaceutical companies.